Clinical trial
AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities
NCT07410403 is registered in ClinicalTrials.gov with Fuling Zhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities
- Lead sponsor
- Fuling Zhou
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 1, 2018
- Completion date
- December 31, 2026
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.